In addition, the receptor tyrosine kinase c-MET, known to exert a major role in tumor formation and progression, has been shown to be induced in hypoxic cancers in general [7], and in advanced or androgen-receptor-independent prostate cancer in particular [8], especially in bone metastases [9]. The gene discussed is MET; the disease is neoplasm.